Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

BACKGROUND: Chronic hepatitis C (CHC) is one of the most important comorbidities in patients with hereditary bleeding disorders (HBD). The present study aimed at evaluating the effectiveness of direct-acting antiviral agent (DAA)-based interferon-free HCV antiviral regimens in patients with HBD. PAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharafi, Heidar, Behnava, Bita, Azizi-saraji, Alireza, Namvar, Ali, Anvar, Ali, Salimi, Shima, Alavian, Seyed Moayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496886/
https://www.ncbi.nlm.nih.gov/pubmed/34620204
http://dx.doi.org/10.1186/s12985-021-01659-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496886/
https://www.ncbi.nlm.nih.gov/pubmed/34620204
http://dx.doi.org/10.1186/s12985-021-01659-0

Ejemplares similares